Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEBO Scar Ointment (also known as MEBO S) is a topical herbal ointment developed by MEBO Group and manufactured in partnership with Julphar. Formulated with natural ingredients including sesame oil, cactus extract, and beeswax, the ointment is rich in active components such as beta-sitosterol, linoleic acid, and tyramine. It is designed to prevent and treat various types of scars, including hypertrophic, keloid, acne, and surgical scars, as well as stretch marks. MEBO Scar Ointment works by creating a protective, moisture-retentive barrier that supports natural skin healing, restrains fibroblast hyperplasia, promotes epithelial cell growth, and facilitates the regeneration of sebaceous glands to restore normal skin structure and function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MEBO Scar Ointment.